Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy;Vorhersage des risikos permanenter atrioventrikulärer überleitungsstörungen nach perkutaner septumablation bei patienten mit hypertropher obstruktiver kardiomyopathie

Zeitschrift fur Kardiologie

Volumn 92, Issue 1, 2003, Pages 39-47

  Faber, Lothar ^a   Seggewiss, Hubert ^b   Welge, Dirk ^a   Fassbender, Dieter ^a   Ziemssen, Peer ^b   Schmidt, Henning K ^a   Gleichmann, Ulrich ^a   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Leopoldina Krankenhaus   (Germany)

Author keywords

DDD pacemaker; Hypertrophic obstructive cardiomyopathy; Left ventricular outflow tract gradient; Percutaneous transluminal septal myocardial ablation; Risk stratification; Total atrioventricular block

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; BRADYCARDIA; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; CONVALESCENCE; DECISION MAKING; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMPLANT; PATIENT MONITORING; RISK FACTOR; TREATMENT PLANNING;

ADULT; AGED; BUNDLE-BRANCH BLOCK; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART BLOCK; HEART SEPTUM; HUMANS; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; RISK ASSESSMENT; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 12244290588     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0878-7     Document Type: Article

References (25)

1. Braunwald E (1997) Induced septal infarction: A new strategy for hypertrophic obstructive cardiomyopathy. Circulation 95:1981
2. Faber L, Seggewiss H, Fassbender D, Strick S, Gleichmann U (1998) Guiding of PTSMA in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography: A case report. J Interven Cardiol 11:443-448
3. Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intra-procedural myocardial contrast echocardiography. Circulation 98:2415-2421
4. Faber L, Seggewiss H, Ziemssen P (2000) Targeting percutaneous transluminal septal ablation for HOCM by intra-procedural echocardiographic monitoring. J Am Soc Echocardiogr 13:1074-1079
5. Faber L, Meissner A, Ziemssen P, Seggewiss H (2000) Percutaneous transluminal septal myocardial ablation for HOCM: Long-term follow-up in the first series of 25 patients. Heart 83:326-331
6. Faber L, Sürig M, Dumitriu M, Ylinen T, Schäfers S, Kostic N, Klempt HW (1994) Dynamic intracavity gradients: A "new" hemodynamic abnormality in the spectrum of secondary left ventricular hypertrophy. Cardiology 84:65-78
7. Faber L, Seggewiss H (2002) Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomopathy: A single center 5 years experience. Journal of the Israel Heart Society 12:14-19
8. Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, Kuhn H (1999) Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Eur Heart J 20:1342-1354
9. Heric B, Lytle BW, Miller OP (1995) Surgical management of hypertrophic obstructive cardiomyopathy. J Thor Cardiovasc Surg 110:195-208
10. Knight CJ, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U (1997) Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 95:2075-2081
11. Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Eur Heart J 18:846-851
12. Lakkis NM, Nagueh SF; Kleiman NS, Killip DM, He ZX, Verani M, Roberts R, Spencer WH III (1998) Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 98:1750-1755
13. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik JA, Spencer WH (2001) Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38:1707-1710
14. Robbins RC, stinson EB, Daily PO (1996) Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 111:586-594
15. Sahn DJ, De Maria AN, Kisslo J, Weyman A (1978) The committee on m-mode standardization of the American Society of Echocardiography. Circulation 58:1072-1078
16. Schulte HD, Gramsch-Zabel H, Schwartzkopff B (1995) Hypertrophische obstruktive Kardiomyopathie: Chirurgische Behandlung Schweiz Med Wochenschr 125:1940-1949
17. Schulte HD, Bircks W, Lösse B (1987) Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM). Z Kardiol 76(supp 3):145-151
18. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol 31:252-258
19. Seggewiss H, Faber L, Ziemssen P (1999) Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Cardiology in review 7:316-323
20. Seggewiss H (2001) Current status of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy. Curr Cardiol Rep 3:160-166
21. Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211-214
22. Spirito P, Seidman CE, Mc Kenna WJ, Maron BJ (1997) The managemant of hypertrophic cardiomyopathy. New Engl J Med 336:775-785
23. Strunk-Mueller C, Gietzen F, Kuhn H (1997) EKG- und elektrophysiologische Befunde nach transkoronarer Ablation der Septum- hypertrophie (TASH) bei Hypertrophisch-obstruktiver Kardiomyopathie (HOCM). Z Kardiol 86(Supp 2):639
24. Sürig M, Faber L, Ylinen T, Michalowski Z, Klempt HW (1995) Die provozierbare (latente) Obstruktion des linksventrikulären Ausflusstraktes. Dtsch med Wschr 120:945-952
25. Wigle DE, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 92:1680-1692